MedTrace Logo

Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

NCT06346080 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2200

Last updated 2026-02-18

No results posted yet for this study

Summary

The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer.

The main question it aims to answer are:

* Which diagnostic modality is preferred by patients and the general population?
* Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality?
* Are geographical differences present in regard to the preference for a diagnostic modality?

Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.

Conditions

Interventions

OTHER

Survey

Discrete choice survey

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Stijn Vanstraelen, MD · UZ Leuven

  • Philippe Nafteux, MD, PhD · UZ Leuven

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2026-08-01
Completion
2026-08-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06346080 on ClinicalTrials.gov